These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 23275471)
21. Misexpression of CCAAT/enhancer binding protein beta causes osteopenia. Zanotti S; Stadmeyer L; Smerdel-Ramoya A; Durant D; Canalis E J Endocrinol; 2009 May; 201(2):263-74. PubMed ID: 19218285 [TBL] [Abstract][Full Text] [Related]
22. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity. Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511 [TBL] [Abstract][Full Text] [Related]
23. Early B-cell Factor1 (Ebf1) promotes early osteoblast differentiation but suppresses osteoblast function. Nieminen-Pihala V; Tarkkonen K; Laine J; Rummukainen P; Saastamoinen L; Nagano K; Baron R; Kiviranta R Bone; 2021 May; 146():115884. PubMed ID: 33582307 [TBL] [Abstract][Full Text] [Related]
24. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Geoffroy V; Kneissel M; Fournier B; Boyde A; Matthias P Mol Cell Biol; 2002 Sep; 22(17):6222-33. PubMed ID: 12167715 [TBL] [Abstract][Full Text] [Related]
25. Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton. Yorgan T; Vollersen N; Riedel C; Jeschke A; Peters S; Busse B; Amling M; Schinke T Bone; 2016 Jun; 87():136-46. PubMed ID: 27102824 [TBL] [Abstract][Full Text] [Related]
26. Constitutive activation of IKK2/NF-κB impairs osteogenesis and skeletal development. Swarnkar G; Zhang K; Mbalaviele G; Long F; Abu-Amer Y PLoS One; 2014; 9(3):e91421. PubMed ID: 24618907 [TBL] [Abstract][Full Text] [Related]
27. Degradation of the NOTCH intracellular domain by elevated autophagy in osteoblasts promotes osteoblast differentiation and alleviates osteoporosis. Yoshida G; Kawabata T; Takamatsu H; Saita S; Nakamura S; Nishikawa K; Fujiwara M; Enokidani Y; Yamamuro T; Tabata K; Hamasaki M; Ishii M; Kumanogoh A; Yoshimori T Autophagy; 2022 Oct; 18(10):2323-2332. PubMed ID: 35025696 [TBL] [Abstract][Full Text] [Related]
28. Conditional inactivation of noggin in the postnatal skeleton causes osteopenia. Canalis E; Brunet LJ; Parker K; Zanotti S Endocrinology; 2012 Apr; 153(4):1616-26. PubMed ID: 22334719 [TBL] [Abstract][Full Text] [Related]
29. Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. Samee N; Geoffroy V; Marty C; Schiltz C; Vieux-Rochas M; Levi G; de Vernejoul MC Am J Pathol; 2008 Sep; 173(3):773-80. PubMed ID: 18669617 [TBL] [Abstract][Full Text] [Related]
30. IGF-I Signaling in Osterix-Expressing Cells Regulates Secondary Ossification Center Formation, Growth Plate Maturation, and Metaphyseal Formation During Postnatal Bone Development. Wang Y; Menendez A; Fong C; ElAlieh HZ; Kubota T; Long R; Bikle DD J Bone Miner Res; 2015 Dec; 30(12):2239-48. PubMed ID: 26011431 [TBL] [Abstract][Full Text] [Related]
31. Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance. Baek WY; de Crombrugghe B; Kim JE Bone; 2010 Apr; 46(4):920-8. PubMed ID: 20026264 [TBL] [Abstract][Full Text] [Related]
32. Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual. Davey RA; Clarke MV; Sastra S; Skinner JP; Chiang C; Anderson PH; Zajac JD Transgenic Res; 2012 Aug; 21(4):885-93. PubMed ID: 22160436 [TBL] [Abstract][Full Text] [Related]
33. Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway. Qiu WX; Ma XL; Lin X; Zhao F; Li DJ; Chen ZH; Zhang KW; Zhang R; Wang P; Xiao YY; Miao ZP; Dang K; Wu XY; Qian AR J Cell Mol Med; 2020 Jan; 24(1):317-327. PubMed ID: 31709715 [TBL] [Abstract][Full Text] [Related]
34. β-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice. Chen J; Long F J Bone Miner Res; 2013 May; 28(5):1160-9. PubMed ID: 23188722 [TBL] [Abstract][Full Text] [Related]
35. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation. Xiong J; Almeida M; O'Brien CA Bone; 2018 Jul; 112():1-9. PubMed ID: 29626544 [TBL] [Abstract][Full Text] [Related]
36. HES1 (hairy and enhancer of split 1) is a determinant of bone mass. Zanotti S; Smerdel-Ramoya A; Canalis E J Biol Chem; 2011 Jan; 286(4):2648-57. PubMed ID: 21084301 [TBL] [Abstract][Full Text] [Related]
37. VEGFA from osteoblasts is not required for lamellar bone formation following tibial loading. McKenzie JA; Galbreath IM; Coello AF; Hixon KR; Silva MJ Bone; 2022 Oct; 163():116502. PubMed ID: 35872107 [TBL] [Abstract][Full Text] [Related]
38. Notch suppresses nuclear factor of activated T cells (NFAT) transactivation and Nfatc1 expression in chondrocytes. Zanotti S; Canalis E Endocrinology; 2013 Feb; 154(2):762-72. PubMed ID: 23264614 [TBL] [Abstract][Full Text] [Related]
39. Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia. Smerdel-Ramoya A; Zanotti S; Stadmeyer L; Durant D; Canalis E Endocrinology; 2008 Sep; 149(9):4374-81. PubMed ID: 18535099 [TBL] [Abstract][Full Text] [Related]